Matinas BioPharma Holdings, Inc. cotiza a 2.50 USD y tiene una capitalización bursátil de $2M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nanocrystals for the delivery of small molecules, nucleic acids, gene therapi…
| Periodo | 2025-08 | 2025-04 | 2024-11 | 2024-08 |
|---|---|---|---|---|
| Real | — | $-12.08 | $-12.75 | $-15.00 |
| Estimado | — | $-11.70 | $-15.82 | $-15.00 |
| Sorpresa | — | -3.2% | +19.4% | +0.0% |
| Métrica | MTNB | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -214.2% | -40.4% | -173.8% |
| ROA | -143.5% | -32.0% | -111.5% |
| Current Ratio | 2.79 | 2.84 | -0.05 |
| Debt / Equity | — | 0.28 | — |